KRTX - Bristol Myers cut at Redburn as looming headwinds cloud buyouts
2024-02-06 08:19:58 ET
More on Bristol-Myers Squibb
- Bristol-Myers Squibb: All Focus On Execution
- Bristol-Myers Squibb: Massive Discount Spells Opportunity
- Bristol-Myers Squibb Company 2023 Q4 - Results - Earnings Call Presentation
- Bristol Myers, 2seventy bio to face FDA panel in March for Abecma decision
- Bristol-Myers Squibb beats in Q4 as Eliquis and Opdivo outperform